Literature DB >> 28266693

Fine-Needle Thyroid Aspiration Biopsy: Clinical Experience at the Endocrinology Clinics of the University Hospital of Puerto Rico.

Milliette Alvarado-Santiago1, Dalitza Alvarez-Valentin1, Oscar Ruiz-Bermudez1, Lorena Gonzalez-Sepulveda2, Myriam Allende-Vigo1, Eduardo Santiago-Rodriguez2, Sona Rivas-Tumanyan2.   

Abstract

OBJECTIVE: This study aimed to establish a profile of the ultrasound-guided thyroid fine-needle aspiration biopsies (FNABs) performed at the endocrinology clinics of the University Hospital of Puerto Rico.
METHODS: A retrospective study was conducted to assess all the thyroid FNABs performed from July 1, 2011, to December 31, 2013. Data on socio-demographic, FNAB cytology, surgery, and histopathology were collected from medical records. A chi-square test was used to assess associations between predictors and outcome. McNemar's test was used to compare FNAB cytology and histopathology results.
RESULTS: A total of 240 FNABs were performed on 192 patients; 91.2% were female. The distribution of the cytological diagnoses was as follows: 181 (75.4%) were benign; 39 (16.3%) were non-diagnostic; 15 (6.3%) were indeterminate; and 5 (2.1%) were malignant. A malignant cytology was more likely in patients younger than 45 y/o than in their older counterparts (p = 0.01); a similar result was found for patients who smoked vs. those who did not (p = 0.02). Benign nodules were more likely to be larger than 1 cm than were those that were malignant (88.2% vs. 25%). Histopathology results were available for 38 nodules; there were no statistically significant differences between the cytology and histopathology results (p>0.05). The sensitivity and specificity for FNAB cytology were 75% and 100%, respectively. Of the nodules with an initial indeterminate cytology (47%), 71% demonstrated, ultimately, benign histopathology.
CONCLUSION: In our study, most of the FNABs performed yielded a benign cytology. A high concordance was shown between cytology and histology. For those with indeterminate cytology, the majority of cases demonstrated benign histopathology. These data suggest the need to implement other approaches, such as the development and subsequent use of molecular markers, to improve our diagnostic and therapeutic strategies, this according to our population-based disease prevalence.

Entities:  

Keywords:  Cytology; Thyroid fine-needle aspiration biopsy; Thyroid nodules

Mesh:

Year:  2017        PMID: 28266693      PMCID: PMC5624044     

Source DB:  PubMed          Journal:  P R Health Sci J        ISSN: 0738-0658            Impact factor:   0.705


  20 in total

1.  On the prevalence of familial nonmedullary thyroid cancer in multiply affected kindreds.

Authors:  N David Charkes
Journal:  Thyroid       Date:  2006-02       Impact factor: 6.568

2.  The impact of assessing specimen adequacy and number of needle passes for fine-needle aspiration biopsy of thyroid nodules.

Authors:  Rachel Redman; Hillary Zalaznick; Ernest L Mazzaferri; Nicole A Massoll
Journal:  Thyroid       Date:  2006-01       Impact factor: 6.568

Review 3.  The Bethesda System For Reporting Thyroid Cytopathology.

Authors:  Edmund S Cibas; Syed Z Ali
Journal:  Am J Clin Pathol       Date:  2009-11       Impact factor: 2.493

4.  Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer.

Authors:  David S Cooper; Gerard M Doherty; Bryan R Haugen; Bryan R Hauger; Richard T Kloos; Stephanie L Lee; Susan J Mandel; Ernest L Mazzaferri; Bryan McIver; Furio Pacini; Martin Schlumberger; Steven I Sherman; David L Steward; R Michael Tuttle
Journal:  Thyroid       Date:  2009-11       Impact factor: 6.568

5.  Diagnostic accuracy of conventional versus sonography-guided fine-needle aspiration biopsy of thyroid nodules.

Authors:  D Danese; S Sciacchitano; A Farsetti; M Andreoli; A Pontecorvi
Journal:  Thyroid       Date:  1998-01       Impact factor: 6.568

6.  A tertiary center's experience with second review of 3885 thyroid cytopathology specimens.

Authors:  Matthew T Olson; Thiraphon Boonyaarunnate; Patricia Aragon Han; Christopher B Umbricht; Syed Z Ali; Martha A Zeiger
Journal:  J Clin Endocrinol Metab       Date:  2013-02-22       Impact factor: 5.958

Review 7.  2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.

Authors:  Bryan R Haugen; Erik K Alexander; Keith C Bible; Gerard M Doherty; Susan J Mandel; Yuri E Nikiforov; Furio Pacini; Gregory W Randolph; Anna M Sawka; Martin Schlumberger; Kathryn G Schuff; Steven I Sherman; Julie Ann Sosa; David L Steward; R Michael Tuttle; Leonard Wartofsky
Journal:  Thyroid       Date:  2016-01       Impact factor: 6.568

8.  NCCN Task Force report: Evaluating the clinical utility of tumor markers in oncology.

Authors:  Phillip G Febbo; Marc Ladanyi; Kenneth D Aldape; Angelo M De Marzo; M Elizabeth Hammond; Daniel F Hayes; A John Iafrate; R Kate Kelley; Guido Marcucci; Shuji Ogino; William Pao; Dennis C Sgroi; Marian L Birkeland
Journal:  J Natl Compr Canc Netw       Date:  2011-11       Impact factor: 11.908

9.  Routine second-opinion cytopathology review of thyroid fine needle aspiration biopsies reduces diagnostic thyroidectomy.

Authors:  Tomer Davidov; Stanley Z Trooskin; Beth-Ann Shanker; Dana Yip; Oliver Eng; Jessica Crystal; Jun Hu; Victoriya S Chernyavsky; Malik F Deen; Michael May; Renee L Artymyshyn
Journal:  Surgery       Date:  2010-12       Impact factor: 3.982

10.  Role of ultrasound-guided fine-needle aspiration biopsy in evaluation of nonpalpable thyroid nodules.

Authors:  P Hagag; S Strauss; M Weiss
Journal:  Thyroid       Date:  1998-11       Impact factor: 6.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.